A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
Crohn's Disease
About this trial
This is an interventional prevention trial for Crohn's Disease
Eligibility Criteria
Inclusion Criteria: Established diagnose of Crohn's disease Age 8-18 years, both sexes Weight above 40 kg Oral maintenance treatment with 5-ASA and any concomitant antinflammatory medication (maintained at the same dose during the study) before inclusion is permitted, written informed consent obtained (patient and his/her guardian) Exclusion Criteria: Patients with a history of allergy to salicylates Patients with known significant hepatic or renal function abnormalities Positive enteric pathogens in stool (Salmonella, Shigella, Yersinia, Campylobacter) Pregnant or lactating women Patients with a known history of disease, including mental/emotional disorder, that would interfere with their participation in the study, Patients who participated in another clinical study in the last 3 months, Patients who are unable to comply with the requirements of the protocol Patients who are unable to fill in the diary cards
Sites / Locations
- Faculty Hospital Bulovka, Paediatric Clinic
- Faculty Hospital Motol, Paediatric Clinic